Preventing Pulmonary Aspergillosis: Can We Breathe Easy?
- 18 February 2020
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 104 (12), 2473-2474
- https://doi.org/10.1097/tp.0000000000003188
Abstract
An abstract is unavailable. This article is available as a PDF only.This publication has 10 references indexed in Scilit:
- Late Onset Invasive Pulmonary Aspergillosis in Lung Transplant Recipients in the Setting of a Targeted Prophylaxis/Preemptive Antifungal Therapy StrategyTransplantation, 2020
- Invasive Aspergillosis in solid‐organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of PracticeClinical Transplantation, 2019
- A strategy for prevention of fungal infections in lung transplantation: Role of bronchoalveolar lavage fluid galactomannan and fungal cultureThe Journal of Heart and Lung Transplantation, 2018
- A Case for Antifungal StewardshipCurrent Fungal Infection Reports, 2018
- Voriconazole and squamous cell carcinoma after lung transplantation: A multicenter studyAmerican Journal of Transplantation, 2017
- Antifungal stewardship considerations for adults and pediatricsVirulence, 2016
- Voriconazole-induced periostitis: a new rheumatic disorderClinical Rheumatology, 2016
- Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national surveyTransplant Infectious Disease, 2015
- Risk Factors for Voriconazole Hepatotoxicity at 12 Weeks in Lung Transplant RecipientsAmerican Journal of Transplantation, 2012
- Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)Clinical Infectious Diseases, 2010